The present invention relates to a prolonged-release pharmaceutical composition comprising quetiapine or a pharmaceutically acceptable salt thereof, preferably quetiapine hemifumarate, and propylene glycol alginate (PGA). The present invention further relates to the use of PGA for providing prolonged-release of a pharmaceutically active ingredient from a pharmaceutical composition.
展开▼
